Harris Carla A 4

What Happened

• Carla A. Harris, a MetLife, Inc. (MET) director, was credited with 43 shares as an award/acquisition on March 10, 2026. The shares are recorded at $70.60 each, for a total value of about $3,036.
• This was not an open-market purchase or sale but reflects an imputed reinvestment of dividends into deferred shares under MetLife’s Deferred Compensation Plan for Non-Management Directors.

Key Details

• Transaction date and price: March 10, 2026 — 43 shares at $70.60/share (total ~$3,036).
• Shares owned after transaction: Not specified in the filing.
• Footnote: Imputed reinvestment of dividends on deferred shares per the MetLife Deferred Compensation Plan for Non-Management Directors; deferred shares are stock amounts that became payable but were deferred by the director.
• Filing timeliness: Report filed March 12, 2026 (two days after the transaction); appears timely under Form 4 rules.

Context

• This transaction is a routine dividend reinvestment into deferred compensation and differs from a direct buy or sell in the open market. Such awards typically reflect plan mechanics rather than a personal directional bet on the stock.
• Transaction code: "A" denotes an award or other acquisition; here it represents reinvested dividends converted into deferred shares.